Affiliation:
1. Engineering Research Center of Molecular and Neuro Imaging of the Ministry of Education, School of Life
Science and Technology, Xidian University, Xi’an, Shaanxi, 710071, China
2. Department of Radiation Oncology,
General Hospital of Ningxia Medical University, Yinchuan, Ningxia, 750004, China
Abstract
Background::
As an important determinant in drug discovery, the accurate
analysis and acquisition of pharmacokinetic parameters are very important for the clinical
application of drugs. At present, the research and development of new drugs mainly
obtain their pharmacokinetic parameters through data analysis, physiological model construction
and other methods, but the results are often quite different from the actual situation,
needing more manpower and material resources.
Objective::
We mainly discuss the application of machine learning technology in the prediction
of pharmacokinetic parameters, which are mainly related to the quantitative study
of drug absorption, distribution, metabolism and excretion in the human body, such as
bioavailability, clearance, apparent volume of distribution and so on.
Method::
This paper first introduces the pharmacokinetic parameters, the relationship between
the quantitative structure-activity relationship model and machine learning, then
discusses the application of machine learning technology in different prediction models,
and finally discusses the limitations, prospects and future development of the machine
learning model in predicting pharmacokinetic parameters.
Results::
Unlike traditional pharmacokinetic analysis, machine learning technology can
use computers and algorithms to speed up the acquisition of pharmacokinetic parameters
to varying degrees. It provides a new idea to speed up and shorten the cycle of drug development,
and has been successfully applied in drug design and development.
Conclusion::
The use of machine learning technology has great potential in predicting
pharmacokinetic parameters. It also provides more choices and opportunities for the design
and development of clinical drugs in the future.
Funder
National Natural Science Foundation of China
Open Funding Project of National Key Laboratory of Human Factors Engineering
Natural Science Basic Research Plan in Ningxia Province of China
Key Research and Development Program in Ningxia Province of China
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献